bristol myers squibb ceo on the latest advances in cancer treatment
Published 3 years ago • 6K plays • Length 3:06Download video MP4
Download video MP3
Similar videos
-
5:34
bristol myers squibb ceo on cancer drug pipeline
-
4:12
bristol myers ceo on company's cancer treatment pipeline
-
2:34
bristol-myers squibb ceo on $13 billion myokardia acquisition: 'potentially revolutionary medicine'
-
5:52
biotech boom ahead in 2024, top jefferies analyst predicts on heels of bristol meyers-karuna deal
-
7:42
we got a number of important drugs from the celgene acquisition, says bristol myers squibb ceo
-
3:30
what is immuno-oncology treatment for cancer?
-
39:59
survivorship today: in her shoes: life as a black woman cancer survivor
-
26:58
gvcc 2022: opening keynote- sponsored by bristol myers squibb and gryt health
-
1:36
bristol myers squibb ceo expects zeposia to renew company's medicine portfolio
-
9:05
bristol-myers ceo says the company is in transition
-
7:03
bristol-myers squibb ceo on the drug pipeline, 2020 outlook and more
-
1:08
bristol meyers squibb ceo on company's drug supply line
-
2:23
revolution in the fight against cancer: new research and treatments unveiled #canser #doctorsai
-
1:38
ceos of pioneer natural resources and bristol-myers squibb to retire
-
7:26
bristol-myers squibb ceo: the real value in acquiring celgene | mad money | cnbc
-
5:52
bristol myers ceo on covid drug trials, acquisitions, texas plant
-
10:00
ceo of drugmaker bristol myers sees 'real need' for policy reform on prescription pricing
-
5:15
mai capital's grisanti offers 3 buys and a bail: bristol myers squibb, verizon, hershey & boeing
-
2:46
the state of pharmaceuticals: bristol-myers squibb's plan to buy rayzebio
-
1:42
bristol myers squibb to buy karuna therapeutics for $14 billion in cash
-
6:07
bristol-myers' celgene acquisition is the start of pharmaceutical industry mergers: analyst
-
1:16
bristol myers squibb ceo: with karxt we'll be able to deliver good accuracy without the side effects